Syngen Biotech Co.,Ltd. (TPEX: 8279)

Syngen Biotech Co.,Ltd. Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	228.31	366.89	246.05	314.8	423.42	519.39
Cash & Short-Term Investments	228.31	366.89	246.05	314.8	423.42	519.39
Cash Growth	-28.87%	49.11%	-21.84%	-25.65%	-18.48%	304.05%
Accounts Receivable	477.2	387.8	472.06	388.16	298.71	299.67
Other Receivables	0	0	0	0	-	0.02
Receivables	477.2	387.8	472.06	388.16	298.71	299.69
Inventory	297.5	348.99	369.35	291.96	259.78	226.59
Prepaid Expenses	40.44	28.77	25.42	23.17	34.92	27.58
Total Current Assets	1,043	1,132	1,113	1,018	1,017	1,073
Property, Plant & Equipment	1,544	1,526	1,543	1,035	1,035	752.52
Long-Term Investments	325.19	331.74	313.75	293.55	2.7	3.06
Other Intangible Assets	25.2	24.13	22.96	23.42	27.32	29.87
Long-Term Deferred Tax Assets	19.83	17.44	16.21	12.32	10.39	9.33
Other Long-Term Assets	40.94	73.21	58.7	28.23	28.94	59.43
Total Assets	3,001	3,106	3,071	2,416	2,127	1,928
Accounts Payable	347.34	226.47	248.45	236.86	140.59	161.1
Accrued Expenses	-	72.8	79.89	64.72	3.94	3.29
Short-Term Debt	-	80	230	-	50	-
Current Portion of Long-Term Debt	59.03	59.03	-	-	-	-
Current Portion of Leases	14.88	13.38	14.85	13.7	14.11	11.11
Current Income Taxes Payable	22.83	62.06	76.99	58.39	28.12	34.83
Current Unearned Revenue	27.33	20.04	6.73	6.55	1.97	2.63
Other Current Liabilities	0.32	50.81	62.56	38.4	73.27	79.68
Total Current Liabilities	471.73	584.58	719.47	418.61	312	292.64
Long-Term Debt	178.7	222.97	182	50	-	-
Long-Term Leases	164.11	163.1	173.93	172.39	186.17	142.3
Long-Term Deferred Tax Liabilities	4.13	3.98	3.93	3.16	2.58	2.05
Other Long-Term Liabilities	-	-	-	-	-	0.02
Total Liabilities	818.68	974.63	1,079	644.16	500.74	437.01
Common Stock	271.01	271.01	271.01	271.01	271.01	271.01
Additional Paid-In Capital	-	618.2	618.06	612.83	610.54	610.54
Retained Earnings	1,289	1,243	1,103	887.88	744.67	609.94
Comprehensive Income & Other	622.86	-0.26	-0.07	-0.36	-0.12	0
Shareholders' Equity	2,183	2,132	1,992	1,771	1,626	1,491
Total Liabilities & Equity	3,001	3,106	3,071	2,416	2,127	1,928
Total Debt	416.72	538.49	600.78	236.08	250.28	153.41
Net Cash (Debt)	-188.41	-171.6	-354.73	78.72	173.14	365.98
Net Cash Growth	-	-	-	-54.53%	-52.69%	-
Net Cash Per Share	-6.95	-6.33	-13.07	2.90	6.38	15.22
Filing Date Shares Outstanding	27.08	27.1	27.1	27.1	27.1	27.1
Total Common Shares Outstanding	27.08	27.1	27.1	27.1	27.1	27.1
Working Capital	571.72	547.87	393.41	599.48	704.84	780.62
Book Value Per Share	80.61	78.66	73.49	65.36	60.00	55.03
Tangible Book Value	2,158	2,107	1,969	1,748	1,599	1,462
Tangible Book Value Per Share	79.68	77.76	72.64	64.50	58.99	53.93
Land	-	251	251	-	-	-
Buildings	-	717.09	702.28	532.98	529.5	378.36
Machinery	-	871.44	841.51	693.37	656.19	559.92
Construction In Progress	-	146.33	114.01	111.97	79.98	33.17

Source: S&P Capital IQ. Standard template. Financial Sources.